CLINICAL_TRIALS
trial_result
· 2017-05-12
Clinical Trial Update: Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index [Phase 2]
Summary
Phase 2 trial evaluating LIK066 for body weight reduction in individuals with elevated body mass index; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Elevated Body Mass Index | Phase 2 | Status: COMPLETED | Results posted: 2017-05-12